Financial Summary (All financials)
| In millions, except per share items | Mar-25-23 | Mar-26-22 | Mar-27-21 | Mar-28-20 | Mar-30-19 | Mar-31-18 | Mar-25-17 | Mar-26-16 |
| Revenues | 1,897.6 | 1,781.5 | 1,369.2 | 1,281.1 | 1,185.5 | 1,532.2 | 1,538.9 | 1,169.3 |
| Revenue growth | 6.5% | 30.1% | 6.9% | 8.1% | -22.6% | -0.4% | 31.6% | 27.6% |
| Cost of goods sold | 940.6 | 857.8 | 661.9 | 607.0 | 588.0 | 771.5 | 781.1 | 614.4 |
| Gross profit | 957.0 | 923.6 | 707.3 | 674.2 | 597.5 | 760.7 | 757.8 | 554.8 |
| Gross margin | 50.4% | 51.8% | 51.7% | 52.6% | 50.4% | 49.6% | 49.2% | 47.5% |
| Selling, general and administrative | 153.1 | 151.0 | 127.0 | 131.1 | 126.5 | 131.8 | 127.3 | 117.1 |
| Research and development | 458.4 | 406.3 | 342.8 | 347.6 | 375.1 | 366.4 | 303.7 | 269.2 |
| EBITA | 379.1 | 395.3 | 252.0 | 223.7 | 129.9 | 316.2 | 364.3 | 215.9 |
| EBITA margin | 20.0% | 22.2% | 18.4% | 17.5% | 11.0% | 20.6% | 23.7% | 18.5% |
| Amortization of intangibles | 33.7 | 29.0 | 14.5 | 28.3 | 47.8 | 53.7 | 37.4 | 35.7 |
| EBIT | 345.4 | 366.3 | 237.5 | 195.4 | 82.1 | 262.5 | 326.9 | 180.2 |
| EBIT margin | 18.2% | 20.6% | 17.3% | 15.3% | 6.9% | 17.1% | 21.2% | 15.4% |
| Pre-tax income | 254.7 | 368.7 | 245.2 | 181.3 | 93.7 | 265.1 | 315.0 | 176.0 |
| Income taxes | 78.0 | 42.3 | 27.9 | 21.8 | 3.8 | 103.1 | 53.8 | 52.4 |
| Tax rate | 30.6% | 11.5% | 11.4% | 12.0% | 4.0% | 38.9% | 17.1% | 29.8% |
| Net income | 176.7 | 326.4 | 217.3 | 159.5 | 90.0 | 162.0 | 261.2 | 123.6 |
| Net margin | 9.3% | 18.3% | 15.9% | 12.4% | 7.6% | 10.6% | 17.0% | 10.6% |
| |
| Diluted EPS | $3.09 | $5.52 | $3.62 | $2.64 | $1.46 | $2.46 | $3.92 | $1.87 |
| Shares outstanding (diluted) | 57.2 | 59.1 | 60.1 | 60.5 | 61.6 | 66.0 | 66.6 | 66.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|